# Etodolac

## Lonine 200mg

| 藥物代碼           | OLON                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Osteoarthritis. Pain. Rheumatoid arthritis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用             | CommonCardiovascular: Edema (1% to 10% )Gastrointestinal: Abdominal pain (3% to 9% ), Diarrhea (3% to 9% ), Flatulence (3% to 9% ), Indigestion (10% ), Nausea (3% to 9% )Hepatic: Increased liver function test (up to 15% )Neurologic: Dizziness (3% to 9% ), Headache (3% to 4% )Other: Malaise (3% to 9% )SeriousCardiovascular: Congestive heart failure (less than 1% ), Hypertension (less than 1% ), Myocardial infarction (less than 1% ), Thrombotic tendency observationsDermatologic: Erythroderma, Stevens-Johnson syndrome (less than 1% ), Toxic epidermal necrolysis (less than 1% )Gastrointestinal: Gastrointestinal hemorrhage, Gastrointestinal perforation, Gastrointestinal ulcer, Inflammatory disorder of digestive tractHematologic: Thrombocytopenia (less than 1% )Hepatic: Hepatic necrosis, Hepatitis (less than 1% ), Liver failure (less than 1% )Immunologic: Anaphylactoid reaction (less than 1% )Neurologic: Cerebrovascular accidentRenal: Acute renal failure (less than 1% ), Papillary necrosis (less than 1% )Respiratory: Bronchospasm |
| 禁忌               | Asthma, urticaria, or allergic-type reaction following aspirin or other NSAID administration; severe, even fatal anaphylactic-like reactions have been reported. hypersensitivity to etodolac. CABG surgery within 14 days, treatment of perioperative pain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 藥物保存方式       | 攝氏25度C以下                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量           | Pain: 200 to 400 mg ORALLY every 6 to 8 h as needed; max 1200 mg/day. Rheumatoid arthritis: 300 mg ORALLY two or three times a day OR 400-500 mg ORALLY two times a day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 肝功能異常         | 無需調整劑量  In patients with compensated hepatic cirrhosis, the dose of etodolac does not need to be adjusted. However, the dose may need to be decreased in patients with severe hepatic failure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 孕期用藥建議       | Human data suggest risk in 1st and 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | [仿單]用於孕婦:由動物實驗顯示,在2~10mg/kg的每日劑量下,此藥對大鼠或家免均無致胎性或胚胎毒性. 在3~15mg/kg的每日劑量下,對於雄鼠及雄鼠的生育力和全面的生殖表現,以及這些雌鼠所產下的後代,都只有很小的影響. 據實驗證明,若懷孕動物使用抑制前列腺素生物合成的藥物,可能會導致難產或延遲生產. 由針對每天服用LONINE 3~15 mg/kg的大鼠於產前產後的情況所進行的研究,發現在每天服用15mg/kg的一組裡,發生難產或孕期延長的母鼠數目,以及每一產的死胎數目,都比平常多. 至於孕婦，目前未有足夠且控制嚴謹的研究結果可循. 因此,對於孕婦,也只有在經過衡量後確定患者可能獲得的利益重於胎兒可能遭受的危害時,才可以使用LONINE,有一部份前列腺素生物合成抑制劑據證實會妨礙動脈導管的閉合; 所以,在懷孕末期三個月裡並不推薦使用LONINE. [20201124非類固醇消炎藥品安全資訊風險溝通表] 懷孕20週以上孕婦使用NSAIDs可能會導致胎兒腎功能障礙並導致羊水過少； 妊娠30週以上之孕婦可能導致胎兒動脈導管過早閉合的風險。                                                                                                                                                                                                   |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | [仿單]用於授乳婦:授乳期間使用LONINE之安全性尚未建立.致癌性,致突變性以及對生育力的損害: 為了評估LONINE的致癌性,會進行一項長達2年的大鼠實驗,以及另一項？期18個月的小鼠實驗; 結果並沒有發現任何致癌性. LONINE亦經Ames氏致突變性測驗證明無致變性.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

